JPS6277312A - Foaming bath agent - Google Patents
Foaming bath agentInfo
- Publication number
- JPS6277312A JPS6277312A JP21865285A JP21865285A JPS6277312A JP S6277312 A JPS6277312 A JP S6277312A JP 21865285 A JP21865285 A JP 21865285A JP 21865285 A JP21865285 A JP 21865285A JP S6277312 A JPS6277312 A JP S6277312A
- Authority
- JP
- Japan
- Prior art keywords
- acid
- gluconolactone
- carbonate
- bath agent
- carbon dioxide
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 238000005187 foaming Methods 0.000 title claims abstract description 6
- 239000013040 bath agent Substances 0.000 title claims abstract 8
- 239000002253 acid Substances 0.000 claims abstract description 18
- PHOQVHQSTUBQQK-SQOUGZDYSA-N D-glucono-1,5-lactone Chemical compound OC[C@H]1OC(=O)[C@H](O)[C@@H](O)[C@@H]1O PHOQVHQSTUBQQK-SQOUGZDYSA-N 0.000 claims abstract description 13
- 235000012209 glucono delta-lactone Nutrition 0.000 claims abstract description 13
- 229960003681 gluconolactone Drugs 0.000 claims abstract description 13
- BVKZGUZCCUSVTD-UHFFFAOYSA-L Carbonate Chemical compound [O-]C([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-L 0.000 claims abstract description 10
- CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 abstract description 38
- 239000001569 carbon dioxide Substances 0.000 abstract description 19
- 229910002092 carbon dioxide Inorganic materials 0.000 abstract description 19
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 abstract description 9
- VZCYOOQTPOCHFL-OWOJBTEDSA-N Fumaric acid Chemical compound OC(=O)\C=C\C(O)=O VZCYOOQTPOCHFL-OWOJBTEDSA-N 0.000 abstract description 6
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 abstract description 6
- OFOBLEOULBTSOW-UHFFFAOYSA-N Malonic acid Chemical compound OC(=O)CC(O)=O OFOBLEOULBTSOW-UHFFFAOYSA-N 0.000 abstract description 4
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 abstract description 4
- KDYFGRWQOYBRFD-UHFFFAOYSA-N Succinic acid Natural products OC(=O)CCC(O)=O KDYFGRWQOYBRFD-UHFFFAOYSA-N 0.000 abstract description 4
- 150000007513 acids Chemical class 0.000 abstract description 4
- BJEPYKJPYRNKOW-REOHCLBHSA-N (S)-malic acid Chemical compound OC(=O)[C@@H](O)CC(O)=O BJEPYKJPYRNKOW-REOHCLBHSA-N 0.000 abstract description 3
- FEWJPZIEWOKRBE-JCYAYHJZSA-N Dextrotartaric acid Chemical compound OC(=O)[C@H](O)[C@@H](O)C(O)=O FEWJPZIEWOKRBE-JCYAYHJZSA-N 0.000 abstract description 3
- FEWJPZIEWOKRBE-UHFFFAOYSA-N Tartaric acid Natural products [H+].[H+].[O-]C(=O)C(O)C(O)C([O-])=O FEWJPZIEWOKRBE-UHFFFAOYSA-N 0.000 abstract description 3
- BJEPYKJPYRNKOW-UHFFFAOYSA-N alpha-hydroxysuccinic acid Natural products OC(=O)C(O)CC(O)=O BJEPYKJPYRNKOW-UHFFFAOYSA-N 0.000 abstract description 3
- 235000015165 citric acid Nutrition 0.000 abstract description 3
- 239000001530 fumaric acid Substances 0.000 abstract description 3
- 235000011087 fumaric acid Nutrition 0.000 abstract description 3
- 239000001630 malic acid Substances 0.000 abstract description 3
- 235000011090 malic acid Nutrition 0.000 abstract description 3
- 229910000029 sodium carbonate Inorganic materials 0.000 abstract description 3
- 235000017550 sodium carbonate Nutrition 0.000 abstract description 3
- 229910000031 sodium sesquicarbonate Inorganic materials 0.000 abstract description 3
- 235000018341 sodium sesquicarbonate Nutrition 0.000 abstract description 3
- 239000011975 tartaric acid Substances 0.000 abstract description 3
- 235000002906 tartaric acid Nutrition 0.000 abstract description 3
- VZCYOOQTPOCHFL-UHFFFAOYSA-N trans-butenedioic acid Natural products OC(=O)C=CC(O)=O VZCYOOQTPOCHFL-UHFFFAOYSA-N 0.000 abstract description 3
- WCTAGTRAWPDFQO-UHFFFAOYSA-K trisodium;hydrogen carbonate;carbonate Chemical compound [Na+].[Na+].[Na+].OC([O-])=O.[O-]C([O-])=O WCTAGTRAWPDFQO-UHFFFAOYSA-K 0.000 abstract description 3
- KDYFGRWQOYBRFD-NUQCWPJISA-N butanedioic acid Chemical compound O[14C](=O)CC[14C](O)=O KDYFGRWQOYBRFD-NUQCWPJISA-N 0.000 abstract description 2
- 238000013329 compounding Methods 0.000 abstract description 2
- -1 etc. Substances 0.000 abstract description 2
- 239000011736 potassium bicarbonate Substances 0.000 abstract description 2
- 229910000028 potassium bicarbonate Inorganic materials 0.000 abstract description 2
- 235000015497 potassium bicarbonate Nutrition 0.000 abstract description 2
- TYJJADVDDVDEDZ-UHFFFAOYSA-M potassium hydrogencarbonate Chemical compound [K+].OC([O-])=O TYJJADVDDVDEDZ-UHFFFAOYSA-M 0.000 abstract description 2
- 229910000030 sodium bicarbonate Inorganic materials 0.000 abstract description 2
- 235000017557 sodium bicarbonate Nutrition 0.000 abstract description 2
- 230000002045 lasting effect Effects 0.000 abstract 1
- 239000000654 additive Substances 0.000 description 18
- 230000000996 additive effect Effects 0.000 description 12
- 239000007789 gas Substances 0.000 description 12
- 230000000694 effects Effects 0.000 description 6
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 4
- 238000003287 bathing Methods 0.000 description 3
- 238000002156 mixing Methods 0.000 description 3
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 2
- WHUUTDBJXJRKMK-VKHMYHEASA-N L-glutamic acid Chemical compound OC(=O)[C@@H](N)CCC(O)=O WHUUTDBJXJRKMK-VKHMYHEASA-N 0.000 description 2
- CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 description 2
- RFMMMVDNIPUKGG-YFKPBYRVSA-N N-acetyl-L-glutamic acid Chemical compound CC(=O)N[C@H](C(O)=O)CCC(O)=O RFMMMVDNIPUKGG-YFKPBYRVSA-N 0.000 description 2
- 229910017709 Ni Co Inorganic materials 0.000 description 2
- AUNGANRZJHBGPY-SCRDCRAPSA-N Riboflavin Chemical compound OC[C@@H](O)[C@@H](O)[C@@H](O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-SCRDCRAPSA-N 0.000 description 2
- UIIMBOGNXHQVGW-DEQYMQKBSA-M Sodium bicarbonate-14C Chemical compound [Na+].O[14C]([O-])=O UIIMBOGNXHQVGW-DEQYMQKBSA-M 0.000 description 2
- 230000002378 acidificating effect Effects 0.000 description 2
- WNLRTRBMVRJNCN-UHFFFAOYSA-N adipic acid Chemical compound OC(=O)CCCCC(O)=O WNLRTRBMVRJNCN-UHFFFAOYSA-N 0.000 description 2
- 230000017531 blood circulation Effects 0.000 description 2
- 230000000052 comparative effect Effects 0.000 description 2
- 238000007796 conventional method Methods 0.000 description 2
- 239000000284 extract Substances 0.000 description 2
- 239000000182 glucono-delta-lactone Substances 0.000 description 2
- 159000000011 group IA salts Chemical class 0.000 description 2
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 2
- 229910052943 magnesium sulfate Inorganic materials 0.000 description 2
- 235000019341 magnesium sulphate Nutrition 0.000 description 2
- 239000000203 mixture Substances 0.000 description 2
- 239000000049 pigment Substances 0.000 description 2
- BWHMMNNQKKPAPP-UHFFFAOYSA-L potassium carbonate Chemical compound [K+].[K+].[O-]C([O-])=O BWHMMNNQKKPAPP-UHFFFAOYSA-L 0.000 description 2
- 230000001737 promoting effect Effects 0.000 description 2
- IXPNQXFRVYWDDI-UHFFFAOYSA-N 1-methyl-2,4-dioxo-1,3-diazinane-5-carboximidamide Chemical compound CN1CC(C(N)=N)C(=O)NC1=O IXPNQXFRVYWDDI-UHFFFAOYSA-N 0.000 description 1
- RTBFRGCFXZNCOE-UHFFFAOYSA-N 1-methylsulfonylpiperidin-4-one Chemical compound CS(=O)(=O)N1CCC(=O)CC1 RTBFRGCFXZNCOE-UHFFFAOYSA-N 0.000 description 1
- ATRRKUHOCOJYRX-UHFFFAOYSA-N Ammonium bicarbonate Chemical compound [NH4+].OC([O-])=O ATRRKUHOCOJYRX-UHFFFAOYSA-N 0.000 description 1
- 241001474374 Blennius Species 0.000 description 1
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 1
- AUNGANRZJHBGPY-UHFFFAOYSA-N D-Lyxoflavin Natural products OCC(O)C(O)C(O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-UHFFFAOYSA-N 0.000 description 1
- UYUXSRADSPPKRZ-SKNVOMKLSA-N D-glucurono-6,3-lactone Chemical compound O=C[C@H](O)[C@H]1OC(=O)[C@@H](O)[C@H]1O UYUXSRADSPPKRZ-SKNVOMKLSA-N 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 239000004166 Lanolin Substances 0.000 description 1
- 108091005804 Peptidases Proteins 0.000 description 1
- 239000004365 Protease Substances 0.000 description 1
- 102100037486 Reverse transcriptase/ribonuclease H Human genes 0.000 description 1
- PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 description 1
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 description 1
- 239000001361 adipic acid Substances 0.000 description 1
- 235000011037 adipic acid Nutrition 0.000 description 1
- 239000001099 ammonium carbonate Substances 0.000 description 1
- 235000012501 ammonium carbonate Nutrition 0.000 description 1
- JFCQEDHGNNZCLN-UHFFFAOYSA-N anhydrous glutaric acid Natural products OC(=O)CCCC(O)=O JFCQEDHGNNZCLN-UHFFFAOYSA-N 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- 239000011230 binding agent Substances 0.000 description 1
- 239000013078 crystal Substances 0.000 description 1
- 125000000422 delta-lactone group Chemical group 0.000 description 1
- 239000007884 disintegrant Substances 0.000 description 1
- 150000002148 esters Chemical class 0.000 description 1
- 230000002349 favourable effect Effects 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 239000003205 fragrance Substances 0.000 description 1
- 229950002441 glucurolactone Drugs 0.000 description 1
- 229960002989 glutamic acid Drugs 0.000 description 1
- 235000011187 glycerol Nutrition 0.000 description 1
- 239000008187 granular material Substances 0.000 description 1
- 241000411851 herbal medicine Species 0.000 description 1
- 150000003840 hydrochlorides Chemical class 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 235000019388 lanolin Nutrition 0.000 description 1
- 229940039717 lanolin Drugs 0.000 description 1
- 239000000314 lubricant Substances 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 239000010446 mirabilite Substances 0.000 description 1
- 238000006386 neutralization reaction Methods 0.000 description 1
- 150000007524 organic acids Chemical class 0.000 description 1
- 235000005985 organic acids Nutrition 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- RECVMTHOQWMYFX-UHFFFAOYSA-N oxygen(1+) dihydride Chemical compound [OH2+] RECVMTHOQWMYFX-UHFFFAOYSA-N 0.000 description 1
- 239000000546 pharmaceutical excipient Substances 0.000 description 1
- 229910000027 potassium carbonate Inorganic materials 0.000 description 1
- 235000011181 potassium carbonates Nutrition 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 229960002477 riboflavin Drugs 0.000 description 1
- 235000019192 riboflavin Nutrition 0.000 description 1
- 239000002151 riboflavin Substances 0.000 description 1
- 235000010413 sodium alginate Nutrition 0.000 description 1
- 239000000661 sodium alginate Substances 0.000 description 1
- 229940005550 sodium alginate Drugs 0.000 description 1
- 229910052938 sodium sulfate Inorganic materials 0.000 description 1
- RSIJVJUOQBWMIM-UHFFFAOYSA-L sodium sulfate decahydrate Chemical compound O.O.O.O.O.O.O.O.O.O.[Na+].[Na+].[O-]S([O-])(=O)=O RSIJVJUOQBWMIM-UHFFFAOYSA-L 0.000 description 1
- 235000011152 sodium sulphate Nutrition 0.000 description 1
- 239000001384 succinic acid Substances 0.000 description 1
- 235000011044 succinic acid Nutrition 0.000 description 1
- 229910052717 sulfur Inorganic materials 0.000 description 1
- 239000011593 sulfur Substances 0.000 description 1
- 150000003467 sulfuric acid derivatives Chemical class 0.000 description 1
- 239000004094 surface-active agent Substances 0.000 description 1
- 230000002459 sustained effect Effects 0.000 description 1
- 239000003826 tablet Substances 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- NWONKYPBYAMBJT-UHFFFAOYSA-L zinc sulfate Chemical compound [Zn+2].[O-]S([O-])(=O)=O NWONKYPBYAMBJT-UHFFFAOYSA-L 0.000 description 1
- 229960001763 zinc sulfate Drugs 0.000 description 1
- 229910000368 zinc sulfate Inorganic materials 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/60—Sugars; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/10—Washing or bathing preparations
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/20—Chemical, physico-chemical or functional or structural properties of the composition as a whole
- A61K2800/22—Gas releasing
- A61K2800/222—Effervescent
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Dermatology (AREA)
- Birds (AREA)
- Epidemiology (AREA)
- Cosmetics (AREA)
Abstract
Description
【発明の詳細な説明】
〔産業上の利用分野〕
本発明は、炭酸ガスの発生に持続性を有する発泡性入浴
剤に関するものである。DETAILED DESCRIPTION OF THE INVENTION [Field of Industrial Application] The present invention relates to an effervescent bath additive that has a sustained ability to generate carbon dioxide gas.
発泡性入浴剤は、一般に浴場中で炭酸ガスや酸素を発生
させるもので、入浴時発泡した泡によって皮膚表面を摩
擦し、湯に溶は込んだ炭酸ガスが、毛細血管を拡張し、
新陳代謝を増進させるものである。Effervescent bath additives generally generate carbon dioxide gas and oxygen in the bath.The bubbles generated during bathing rub the skin surface, and the carbon dioxide dissolved in the hot water dilates capillaries.
It increases metabolism.
従来の炭酸ガスによる発泡性入浴剤は、アルカリ塩類と
酸類との配合により、溶解時に中和反応により炭酸ガス
を発生せしめるもので、アルカリ塩類としては炭酸ナト
リウム、重炭酸ナトリウム、セスキ炭酸ナトリウムのよ
うな炭酸塩が、また酸類としては酒石酸、クエン酸、リ
ンゴ酸、フマル酸、コハク酸等の有機酸が配合される。Conventional effervescent bath additives using carbon dioxide gas generate carbon dioxide gas through a neutralization reaction when dissolved by combining alkaline salts and acids.The alkaline salts include sodium carbonate, sodium bicarbonate, and sodium sesquicarbonate. Organic acids such as tartaric acid, citric acid, malic acid, fumaric acid, and succinic acid are blended as acids.
しかしながら、上記従来の発泡性入浴剤においては、発
生ずる炭酸ガスの気泡が大きく、このため浴場中への炭
酸ガス溶解性に乏しく、炭酸ガスの発生に持続性がなく
、充分に満足しうる入浴効果が得られなかった。However, in the above-mentioned conventional effervescent bath additives, the bubbles of the carbon dioxide gas generated are large, and therefore, the solubility of carbon dioxide gas in the bath is poor, and the generation of carbon dioxide gas is not sustainable, resulting in a fully satisfactory bathing experience. No effect was obtained.
本発明は、上記従来例の問題点を解決するために、炭酸
塩と酸を含有する入浴剤において、グルコノラクトンを
酸に代えて、又は酸と共に配合したものである。In order to solve the problems of the above-mentioned conventional methods, the present invention is a bath additive containing carbonate and acid, in which gluconolactone is added instead of acid or together with acid.
本発明において、炭酸塩としては、炭酸水素ナトリウム
、炭酸ナトリウム、セスキ炭酸ナトリウム、重炭酸カリ
ウム、炭酸カリウム、炭酸アンモニウム等の単独、若し
くは２４Φ以上を組合せて用いることができる。In the present invention, as the carbonate, sodium bicarbonate, sodium carbonate, sodium sesquicarbonate, potassium bicarbonate, potassium carbonate, ammonium carbonate, etc. can be used alone or in combination of 24Φ or more.
グルコノラクトンは、４位の水酸基の関与するグルコノ
−Ｔ−ラクトンおよび同じ（５位のグルコノ−δ−ラク
トンの２種があり、本発明においては共に使用可能であ
る。There are two types of gluconolactone: glucono-T-lactone, which has a hydroxyl group at the 4-position, and glucono-δ-lactone, which has a hydroxyl group at the 5-position, and both can be used in the present invention.
本発明において、酸としては、酒石酸、クエン酸、リン
ゴ酸、フマル酸、コハク酸、Ｄ−グルクロン酸ラクトン
、マロン酸、グルタル酸、アジピン酸、Ｌ−グルタミン
酸、Ｎ−アセチル−Ｌ−グルタミン酸等の単独、若しく
は２種以上を組合せて用いることができる。In the present invention, acids include tartaric acid, citric acid, malic acid, fumaric acid, succinic acid, D-glucuronic acid lactone, malonic acid, glutaric acid, adipic acid, L-glutamic acid, N-acetyl-L-glutamic acid, etc. They can be used alone or in combination of two or more.
本発明において、炭酸塩とグルコノラクトンとの配合割
合は、通常前者１に対し後者１〜３の割合で用いられる
が、これに限定されるものではない。In the present invention, the blending ratio of carbonate and gluconolactone is usually 1 to 3 for the former, but is not limited to this.
本発明において、入浴剤成分中の上記炭酸塩とグルコノ
ラクトンとの組成物の配合割合については、通常１０〜
９５重量％、好ましくは３０〜９０重量％が用いられる
。In the present invention, the composition ratio of the carbonate and gluconolactone in the bath additive components is usually 10 to 10.
95% by weight is used, preferably 30-90% by weight.
尚、本発明の入浴剤で発生する炭酸ガスは、浴湯のｐＨ
により浴場中での存在状態が異なる。すなわち、炭酸カ
スはｐＨが酸性の場合にはＣＯ□分子として存在し、ｐ
Ｈがアルカリ性の場合には００３′−イオンあるいは肛
０３−イオンとして存在するが、炭酸ガスが浴場中でＣ
Ｏ２分子として存在する場合には、血行促進効果が増大
され、肌に好ましい影舌を与えるので、本発明の入浴剤
は浴場中に溶解さゼたときのｐＨが５〜７の弱酸性にな
るようにするのが好ましい。In addition, the carbon dioxide gas generated by the bath additive of the present invention depends on the pH of the bath water.
The state of existence in the bathhouse differs depending on the situation. In other words, carbon dioxide scum exists as CO□ molecules when the pH is acidic, and p
When H is alkaline, it exists as 003'-ion or 03-ion, but carbon dioxide gas is
When present as O2 molecules, the effect of promoting blood circulation is increased and gives a favorable effect on the skin, so that the bath additive of the present invention has a slightly acidic pH of 5 to 7 when dissolved in a bath. It is preferable to do so.
本発明の入浴剤は、上記成分以外の公知の成分を配合す
ることができる。代表的な例をあげれば次のものを例示
することができる。例えば硫酸ナトリウム、硫酸マグネ
シウム、硫酸亜鉛等の硫酸塩あるいは塩化す１−リウム
等の塩酸塩等、さらには香料、色素、エステル類、ビタ
ミン類（リボフラビン等）、各種温泉成分（イオウ等）
、酵素（プロテアーゼ等）、グリセリン、海草エキス、
アルギン酸ナトリウム、ラノリン界面活性剤、生薬ある
いはその抽出物を挙げつる。The bath additive of the present invention may contain known components other than the above-mentioned components. Typical examples include the following: For example, sulfates such as sodium sulfate, magnesium sulfate, zinc sulfate, hydrochlorides such as 1-lium chloride, fragrances, pigments, esters, vitamins (riboflavin, etc.), and various hot spring ingredients (sulfur, etc.)
, enzymes (protease, etc.), glycerin, seaweed extract,
Examples include sodium alginate, lanolin surfactant, and herbal medicines or their extracts.
また、本発明の入浴剤は粉末、顆粒、結晶、錠剤等の形
にすることができ、これらの製剤化のために必要に応じ
て、賦形剤、結合剤、崩壊剤、滑沢剤等を添加すること
もできる。Furthermore, the bath additives of the present invention can be in the form of powders, granules, crystals, tablets, etc., and excipients, binders, disintegrants, lubricants, etc. may be added as necessary to formulate these formulations. can also be added.
上記手段を施した結果、本発明の入浴剤は、浴場中で極
微細な気泡を多数性して極めて優れた炭酸ガスの溶解性
を発揮し、持続的に炭酸ガスを発生させる。As a result of the above measures, the bath additive of the present invention produces a large number of extremely fine bubbles in the bath, exhibits extremely excellent solubility of carbon dioxide gas, and continuously generates carbon dioxide gas.
以下、本発明を実施例により詳細に説明する。 Hereinafter, the present invention will be explained in detail with reference to Examples.
実施例１゜
表−■に示す配合比で、本発明の入浴剤５ｈ錠剤を常法
により調製し、４２℃の温水ＩＯＮ中へ投入し、気泡を
発生した時間を測定した。比較例として、市販のに社製
発泡性入浴剤５０ｇ錠剤を同様に測定した。Example 1 A 5-hour bath tablet of the present invention was prepared according to a conventional method using the compounding ratio shown in Table 1, and the tablet was poured into 42° C. hot water ION, and the time required for bubble generation was measured. As a comparative example, a commercially available 50 g tablet of effervescent bath salts manufactured by Ni Co., Ltd. was similarly measured.
（以下余白）
表−■ 配合比（重量％）ト
ク
が
以
以
ポ
リ
〒ｆ
杉
・イ
ク
【
実施例２゜
グルコノ−δ−ラクトン６０部、炭酸水素ナトリラム２
８部、芒硝１１部、香１ｇ＋、色素等適量の配合比で、
本発明の入浴剤を調製し、その１ｇを４０°Ｃの温水１
β中に熔解し、経時ごとの溶存炭酸ガス濃度−を測定し
た。比較例として市販のに社製発泡性入浴剤１ｇを同様
に測定した。(Leaving space below) Table -■ Blending ratio (wt%) Toku is as follows Poly〒f Cedar Iku [Example 2゜60 parts of glucono-δ-lactone, 2 parts of sodium bicarbonate]
With a blending ratio of 8 parts, 11 parts of Glauber's salt, 1 g of incense, and an appropriate amount of pigment, etc.
Prepare the bath additive of the present invention, and add 1 g of it to 40°C warm water.
It was dissolved in β and the dissolved carbon dioxide concentration was measured over time. As a comparative example, 1 g of a commercially available foaming bath additive manufactured by Ni Co., Ltd. was measured in the same manner.
その結果、３時間後及び４時間後の溶存炭酸ガス濃度は
、本実施例がそれぞれ４．５ｚ、３．３χであったのに
対し、Ｋ社製発泡性入浴剤はそれぞれ３．３χ、２．４
χであった。As a result, the dissolved carbon dioxide concentration after 3 hours and 4 hours was 4.5z and 3.3χ, respectively, in this example, while it was 3.3χ and 2x, respectively, in the foaming bath additive manufactured by Company K. .4
It was χ.
実施例３゜
グルコノルδ−ラクトン単独と、他の酸成分との組合せ
を比較するために、表−Ｈに示す配合量の本発明の入浴
剤を調製し、４０℃の温水１１中に溶解し、溶存炭酸ガ
ス濃度を測定した。Example 3 In order to compare the combination of gluconol δ-lactone alone and other acid components, bath additives of the present invention having the amounts shown in Table H were prepared and dissolved in 40°C warm water 11. , dissolved carbon dioxide concentration was measured.
（以下余白）
〔発明の効果〕
以上に述べた如く、本発明の発泡性入浴剤は、炭酸塩と
酸を含有する入浴剤において、グ月どツノラクトンを酸
に代えて、又は酸と共に配合することにより、浴場中で
極微細な気泡を多数才して極めて優れた炭酸ガスの溶解
性を発１；１２ Ｌ、持続的に炭酸ガスを発止させるも
のであり、発泡性入浴剤の有する血行促進効果等の入浴
効果を増大させる等、イ↑れた効果を有している。(The following is a blank space) [Effects of the Invention] As described above, the effervescent bath additive of the present invention is a bath additive containing a carbonate and an acid, in which Guzukidotsunolactone is blended in place of the acid or together with the acid. By creating a large number of microscopic bubbles in the bath, it produces an extremely excellent carbon dioxide solubility of 1;12 L, which continuously releases carbon dioxide gas, and improves the blood circulation that effervescent bath additives have. It has unique effects such as increasing bathing effects such as promoting effects.
代即人弁用１士 辻本−義1st Proxy Practitioner Yoshi Tsujimoto
Claims (1)
クトンを酸に代えて、又は酸と共に配合することを特徴
とする発泡性入浴剤。1. A foaming bath agent containing gluconolactone in place of or together with the acid in a bath agent containing a carbonate and an acid.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP60218652A JPH0639373B2 (en) | 1985-09-30 | 1985-09-30 | Effervescent bath agent |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP60218652A JPH0639373B2 (en) | 1985-09-30 | 1985-09-30 | Effervescent bath agent |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JPS6277312A true JPS6277312A (en) | 1987-04-09 |
| JPH0639373B2 JPH0639373B2 (en) | 1994-05-25 |
Family
ID=16723303
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP60218652A Expired - Lifetime JPH0639373B2 (en) | 1985-09-30 | 1985-09-30 | Effervescent bath agent |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JPH0639373B2 (en) |
Cited By (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH02138209A (en) * | 1989-08-04 | 1990-05-28 | Tadao Shiraishi | Spray type bath agent |
| WO1999043296A2 (en) * | 1998-02-26 | 1999-09-02 | Unilever Plc | Anti-irritants in cosmetic compositions |
| AU2002301446B2 (en) * | 1998-02-26 | 2005-03-24 | Unilever Plc | Gluconolactones and glucarolactones as anti-irritants in cosmetic compositions |
| WO2006080398A1 (en) * | 2005-01-28 | 2006-08-03 | Neochemir Inc. | Composition for preparing carbon dioxide preparation for external use |
| JP2012020221A (en) * | 2010-07-14 | 2012-02-02 | Osaka Gas Co Ltd | Carbon dioxide absorption method |
| JP2016000712A (en) * | 2014-05-22 | 2016-01-07 | 株式会社アイビーティジェイ | Composition for preparing carbon dioxide external agent, preparation method and evaluation method thereof, and carbon dioxide external agent |
Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS57118508A (en) * | 1981-01-14 | 1982-07-23 | Motoyasu Uehara | Bath preparation |
| JPS5970610A (en) * | 1982-10-15 | 1984-04-21 | Kao Corp | Foaming bathing agent |
-
1985
- 1985-09-30 JP JP60218652A patent/JPH0639373B2/en not_active Expired - Lifetime
Patent Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS57118508A (en) * | 1981-01-14 | 1982-07-23 | Motoyasu Uehara | Bath preparation |
| JPS5970610A (en) * | 1982-10-15 | 1984-04-21 | Kao Corp | Foaming bathing agent |
Cited By (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH02138209A (en) * | 1989-08-04 | 1990-05-28 | Tadao Shiraishi | Spray type bath agent |
| WO1999043296A2 (en) * | 1998-02-26 | 1999-09-02 | Unilever Plc | Anti-irritants in cosmetic compositions |
| WO1999043296A3 (en) * | 1998-02-26 | 1999-11-04 | Unilever Plc | Anti-irritants in cosmetic compositions |
| AU2002301446B2 (en) * | 1998-02-26 | 2005-03-24 | Unilever Plc | Gluconolactones and glucarolactones as anti-irritants in cosmetic compositions |
| WO2006080398A1 (en) * | 2005-01-28 | 2006-08-03 | Neochemir Inc. | Composition for preparing carbon dioxide preparation for external use |
| JPWO2006080398A1 (en) * | 2005-01-28 | 2008-06-19 | ネオケミア株式会社 | Carbon dioxide external preparation preparation composition |
| JP4595058B2 (en) * | 2005-01-28 | 2010-12-08 | ネオケミア株式会社 | Carbon dioxide external preparation preparation composition |
| JP2012020221A (en) * | 2010-07-14 | 2012-02-02 | Osaka Gas Co Ltd | Carbon dioxide absorption method |
| JP2016000712A (en) * | 2014-05-22 | 2016-01-07 | 株式会社アイビーティジェイ | Composition for preparing carbon dioxide external agent, preparation method and evaluation method thereof, and carbon dioxide external agent |
Also Published As
| Publication number | Publication date |
|---|---|
| JPH0639373B2 (en) | 1994-05-25 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| KR940007919B1 (en) | Weakly acidic bath salt composition | |
| JPS609009B2 (en) | Foaming bath agent | |
| JPS6277312A (en) | Foaming bath agent | |
| WO1997045103A1 (en) | Effervescent bath tablet compositions | |
| JPS59106415A (en) | Bathing agent | |
| JP2622574B2 (en) | Bath additive | |
| WO2014181852A1 (en) | Bathing agent composition | |
| JPS5970609A (en) | Weakly acidic bathing agent | |
| JPH0545567B2 (en) | ||
| TWI625132B (en) | Cosmetic kit containing bubbling tablet and skin water | |
| JP2558188B2 (en) | Bath agent composition | |
| JP2010037264A (en) | Effervescent bath agent | |
| JPS60185710A (en) | Bath preparation of weak acidity | |
| JPS6178717A (en) | Foamable bathing agent | |
| JPH03112922A (en) | Foamable bathing agent for inhibiting floating of fumaric acid | |
| JP3913918B2 (en) | Bath agent composition | |
| JP2005298454A (en) | Powdery bath preparation composition | |
| JP6829620B2 (en) | Solid bath salt | |
| JPS6245515A (en) | Bathing agent | |
| JPH056524B2 (en) | ||
| JP3481260B2 (en) | Bath agent | |
| JPH0334919A (en) | Bathing agent | |
| JPS60215613A (en) | Weak-acidity bath preparation | |
| JP2010024184A (en) | Swelling-ameliorating composition and method for ameliorating swelling by utilizing the same | |
| JPS60215619A (en) | Weak-acidity bath preparation |